Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Log in to your Inderes Free account to see all free content on this page.
Create account

Kontigo Care

1.88 SEK

+4.16 %

Less than 1K followers

KONT

First North Stockholm

Health Care Providers

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
+4.16 %
+2.17 %
-6.00 %
-12.56 %
-26.56 %
-29.32 %
-54.15 %
-55.87 %
-71.28 %

Kontigo Care is a MedTech company that develops digital solutions for addiction care and workplace safety. The company's platforms enable early detection, treatment and follow-up of addiction problems and contribute to safe, drug-free work environments. Through its technology and evidence-based methods, Kontigo Care aims to create security and increased quality of life for individuals, caregivers and companies. The company was founded in 2013 and is headquartered in Uppsala.

Read more
Market cap
66.27M SEK
Turnover
193.79K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
4.2.
2026

Annual report '25

6.5.
2026

Interim report Q1'26

15.6.
2026

General meeting '26

All
Press releases
ShowingAll content types
Press release11/7/2025, 7:46 AM

Redeye: Kontigo Care (Q3 Review) - Back to growth with profitability on the rise

Kontigo Care
Press release8/20/2025, 8:38 AM

Redeye: Kontigo Care - Q2 2025 – Turning the corner, growth ahead

Kontigo Care
Press release5/13/2025, 8:33 AM

Redeye: Kontigo Care - Transitioning to a MedTech product platform company

Kontigo Care

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Press release2/3/2025, 7:56 AM

Redeye: Kontigo Care - Intensifying business and sales efforts in 2025

Kontigo Care
Press release11/15/2024, 12:14 PM

Redeye: Kontigo Care - Directed share issue of cSEK10.4m

Kontigo Care
Press release11/12/2024, 4:50 PM

Redeye: Kontigo Care Q3 2024 - Positive but complex outlook

Kontigo Care
Press release8/21/2024, 6:36 AM

Redeye: Kontigo Care - Well-positioned to meet the demand for immediate drug detection

Kontigo Care
Press release5/13/2024, 11:45 AM

Redeye: Kontigo Care - Mixed short-term outlook

Kontigo Care
Press release2/5/2024, 7:06 AM

Redeye: Kontigo Care - Investing for growth

Kontigo Care
Press release10/26/2023, 6:41 AM

Redeye: Kontigo Care - Resilient top-line

Kontigo Care
Press release8/23/2023, 6:35 AM

Redeye: Kontigo Care - No trend changes

Kontigo Care
Press release5/17/2023, 6:02 AM

Redeye: Kontigo Care - Gentle start to 2023

Kontigo Care
Press release2/7/2023, 8:52 AM

Redeye: Kontigo Care Q4 2022 - Good conclusion to 2022

Kontigo Care
Press release11/24/2022, 12:37 PM

Redeye: Kontigo Care - Positive outlook, new products in sight

Kontigo Care
Regulatory press release3/28/2022, 7:21 AM

Redeye: Redeye Initiates Coverage of Kontigo Care

Kontigo Care
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.